Skip to main content
OliX Pharmaceuticals, Inc. logo

OliX Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · 226950 ISIN · KR7226950004 KO Manufacturing
Open in API
Filings indexed 365 across all filing types
Latest filing 2022-04-05 Major Shareholding Noti…
Country KR South Korea
Listing KO 226950

About OliX Pharmaceuticals, Inc.

https://olixpharma.com

OliX Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company specializing in the development of therapeutics based on RNA interference (RNAi) technology. The company leverages its proprietary asymmetric siRNA (asiRNA) platform to create treatments that selectively silence disease-causing genes. Its research and development efforts are focused on building a robust pipeline of drug candidates targeting a variety of illnesses with high unmet medical needs. The pipeline has a particular emphasis on ophthalmic and dermal disorders, with key programs addressing conditions such as hypertrophic scars, age-related macular degeneration (AMD), and other fibrotic and ocular diseases.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule report). It details the National Pension Service's change in shareholding percentage in the company 'OliX'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership changes.
2022-04-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details changes in share ownership by major shareholders and special related parties, including specific transaction dates, methods (e.g., open market purchase), and the purpose of holding. It does not fit into categories like 10-K, Earnings Release, or Investor Presentation. Since it is a specific regulatory disclosure regarding shareholding thresholds, it is classified as a Major Shareholding Notification.
2022-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, and the election of directors. This falls under the category of official results from shareholder votes at a general meeting.
2022-03-28 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming investor relations (IR) event (Corporate Day). It provides details such as date, time, location, and purpose, and directs readers to the company website for the actual IR materials. Per the 'Menu vs Meal' rule, since this is a short announcement of an event rather than the presentation itself, it is classified as a Report Publication Announcement (RPA).
2022-03-25 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'OliX' (올릭스 주식회사) for the fiscal year ending December 31, 2021. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and notes to the financial statements. While it contains financial data, it is a standalone audit report rather than a full 10-K annual report or a quarterly report. Therefore, it is classified as an Audit Report. FY 2021
2022-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company 'OliX' on March 15, 2022. It contains the auditor's opinion (적정 - Unqualified), key financial data (assets, liabilities, equity, profit/loss), and details regarding the audit process. While it provides financial data, it is specifically the regulatory filing of the audit report required by the KRX, which falls under the 'Audit Report / Information' category. FY 2021
2022-03-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.